SCHEMBL3393995

SCHEMBL3393995

Cc1cccc(C)c1-c1ccnc(N)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.55
PRKACA P17612 2/20 0.55
AURKA O14965 1/20 0.55
ADORA2A P29274 1/20 0.55
CDK2 P24941 3/20 0.50
CDK4 P11802 2/20 0.50
CCNE1 P24864 1/20 0.50
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HSP90AB1 P08238 1/20 0.49
PTK2 Q05397 1/20 0.49
ROCK1 Q13464 2/20 0.47
MAPT P10636 1/20 0.47
MAP3K14 Q99558 2/20 0.47
JAK2 O60674 3/20 0.45
CDK5 Q00535 2/20 0.45
GSK3B P49841 2/20 0.45
CDC7 O00311 1/20 0.45
PLK4 O00444 1/20 0.45
MAPK13 O15264 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3103196 0.81 PRKACA (0.56) HSP90AA1PRKACAAURKAADORA2ACDK2
SCHEMBL23071629 0.79 HSP90AA1 (0.63) HSP90AA1PRKACAAURKAADORA2ACDK2
SCHEMBL28513246 0.78 HSP90AA1 (0.53) HSP90AA1PRKACAAURKAADORA2ACDK2
SCHEMBL30507455 0.78 HSP90AA1 (0.53) HSP90AA1PRKACAAURKAADORA2ACDK2
SCHEMBL31396451 0.77 JAK2 (0.48) PRKACACDK2CCNE1ROCK1MAP3K14
SCHEMBL28354141 0.76 ADORA2A (0.46) HSP90AA1PRKACAAURKAADORA2AKDM4E
SCHEMBL28771445 0.74 DYRK1A (0.51) HSP90AA1PRKACAAURKAADORA2ACDK2
SCHEMBL14280828 0.73 CCR1 (0.52) HSP90AA1KDM4EALDH1A1MAPK1RAB9A
SCHEMBL13977465 0.73 JAK2 (0.61) HSP90AA1PRKACAAURKAADORA2ACDK2
SCHEMBL3792633 0.73 HSP90AA1 (0.47) HSP90AA1PRKACAAURKAADORA2ACDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed